Organogenesis Holdings (ORGO) Accounts Payables (2017 - 2026)

Organogenesis Holdings' Accounts Payables history runs 10 years deep, the most recent figure standing at $28.6 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 16.04% year-over-year to $28.6 million; the TTM figure through Mar 2026 stood at $28.6 million (up 16.04% YoY), while the FY2025 annual figure was $31.9 million, up 10.51% from the prior year.
• Accounts Payables was $28.6 million for Q1 2026 at Organogenesis Holdings, down from $31.9 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $40.2 million in Q3 2025 to a low of $23.2 million in Q1 2024.
• Historically, Accounts Payables has averaged $30.0 million across 5 years, with a median of $29.4 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Accounts Payables decreased 29.43% in 2023, then jumped 67.78% in 2025.
• A 5-year view of Accounts Payables shows it stood at $32.3 million in 2022, then decreased by 4.97% to $30.7 million in 2023, then slipped by 5.9% to $28.9 million in 2024, then grew by 10.51% to $31.9 million in 2025, then declined by 10.44% to $28.6 million in 2026.
• The last three Accounts Payables figures came in at $28.6 million (Q1 2026), $31.9 million (Q4 2025), and $40.2 million (Q3 2025), per Business Quant data.